Your browser doesn't support javascript.
loading
Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-escalation stage of a multicentre, open-label, phase 1a/b trial.
Friedlander, Michael; Meniawy, Tarek; Markman, Ben; Mileshkin, Linda; Harnett, Paul; Millward, Michael; Lundy, Joanne; Freimund, Alison; Norris, Christie; Mu, Song; Wu, John; Paton, Virginia; Gao, Bo.
Afiliação
  • Friedlander M; Department of Medical Oncology, Nelune Comprehensive Cancer Centre, University of New South Wales Clinical School, Prince of Wales Hospital, Sydney, NSW, Australia. Electronic address: m.friedlander@unsw.edu.au.
  • Meniawy T; Linear Clinical Research, Perth, WA, Australia.
  • Markman B; Monash Health and Monash University, Melbourne, VIC, Australia.
  • Mileshkin L; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Harnett P; Westmead Hospital, Sydney, NSW, Australia.
  • Millward M; Linear Clinical Research, Perth, WA, Australia.
  • Lundy J; Monash Health and Monash University, Melbourne, VIC, Australia.
  • Freimund A; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Norris C; Department of Medical Oncology, Nelune Comprehensive Cancer Centre, University of New South Wales Clinical School, Prince of Wales Hospital, Sydney, NSW, Australia.
  • Mu S; BeiGene, San Mateo, CA, USA.
  • Wu J; BeiGene, San Mateo, CA, USA.
  • Paton V; BeiGene, San Mateo, CA, USA.
  • Gao B; Westmead Hospital, Sydney, NSW, Australia.
Lancet Oncol ; 20(9): 1306-1315, 2019 09.
Article em En | MEDLINE | ID: mdl-31378459
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Anticorpos Monoclonais Humanizados / Fluorenos / Inibidores de Poli(ADP-Ribose) Polimerases / Neoplasias Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Anticorpos Monoclonais Humanizados / Fluorenos / Inibidores de Poli(ADP-Ribose) Polimerases / Neoplasias Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article